US Patent Issued to Double Bond Pharmaceuticals on Nov. 4 for "Oral administration of iron succinate for use in treating iron deficiency in patients having heart failure" (Swedish Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,666, issued on Nov. 4, was assigned to Double Bond Pharmaceuticals AB (Uppsala, Sweden).

"Oral administration of iron succinate for use in treating iron deficiency in patients having heart failure" was invented by Kurt Boman (Skelleftea, Sweden) and Mona Olofsson (Burea, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides an oral pharmaceutical composition comprising iron succinate for use in treating iron deficiency in a subject diagnosed with heart failure (HF) with reduced ejection fraction (HFrEF), and a method for treatment is also provided."

The patent was filed on Nov. 18, 2020, under Application No. 17/770,08...